Major Pharmaceuticals announced a nationwide Class II recall of certain levothyroxine sodium tablets in July 2026 after routine stability testing...
Read More
By submitting your information, you agree to our website Terms and Conditions and our Privacy Policy. You'll also receive our email newsletters, account updates and special offers, sent to you by Patients-Medical.